🕵️ Endra Life Sciences Inc. ($NDRA)
SEC insider & ownership activity, last 12 months · CIK 1681682 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 1 planned sale is pending, the largest $425K (Anthony Digiandomenico). One red-flag 8-K in the window: Delisting notice (3.01), Apr 20, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| John Carter Lipman | 10.0% | 13G | Oct 30, 2025 | filing ↗ | |
| ATW Master Fund V LP | 9.9% | 13G | Oct 28, 2025 | filing ↗ | |
| ATW Partners Opportunities Management, LLC | 9.9% | 13G | Oct 28, 2025 | filing ↗ | |
| Kerry Propper | 9.9% | 13G | Oct 28, 2025 | filing ↗ | |
| Antonio Ruiz-Gimenez | 9.9% | 13G | Oct 28, 2025 | filing ↗ | |
| Anthony Digiandomenico | 9.9% | 13D | Jun 25, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Anthony Digiandomenico | $425K | Jun 26, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 8, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 25, 2026 | filing ↗ |
| Change of control (5.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Material agreement (1.01) | May 27, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 27, 2026 | filing ↗ |
| Other events (8.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 9, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 9, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 28, 2025 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 23, 2025 | filing ↗ |
| Other events (8.01) | Oct 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing ↗ |